These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 37099824)
41. Long-term effectiveness and tolerability of ketogenic diet therapy in patients with genetic developmental and epileptic encephalopathy onset within the first 6 months of life. Song T; Deng J; Chen C; Wang X; Han T; Wang X; Fang T; Tian X; Fang F Epilepsia Open; 2024 Apr; 9(2):643-652. PubMed ID: 38235958 [TBL] [Abstract][Full Text] [Related]
42. A knock-in mouse model for KCNQ2-related epileptic encephalopathy displays spontaneous generalized seizures and cognitive impairment. Milh M; Roubertoux P; Biba N; Chavany J; Spiga Ghata A; Fulachier C; Collins SC; Wagner C; Roux JC; Yalcin B; Félix MS; Molinari F; Lenck-Santini PP; Villard L Epilepsia; 2020 May; 61(5):868-878. PubMed ID: 32239694 [TBL] [Abstract][Full Text] [Related]
43. Clinical study of 19 patients with SCN8A-related epilepsy: Two modes of onset regarding EEG and seizures. Denis J; Villeneuve N; Cacciagli P; Mignon-Ravix C; Lacoste C; Lefranc J; Napuri S; Damaj L; Villega F; Pedespan JM; Moutton S; Mignot C; Doummar D; Lion-François L; Gataullina S; Dulac O; Martin M; Gueden S; Lesca G; Julia S; Cances C; Journel H; Altuzarra C; Ben Zeev B; Afenjar A; Barth M; Villard L; Milh M Epilepsia; 2019 May; 60(5):845-856. PubMed ID: 31026061 [TBL] [Abstract][Full Text] [Related]
44. Personalized treatment with retigabine for pharmacoresistant epilepsy arising from a pathogenic variant in the KCNQ2 selectivity filter. Nissenkorn A; Kornilov P; Peretz A; Blumkin L; Heimer G; Ben-Zeev B; Attali B Epileptic Disord; 2021 Oct; 23(5):695-705. PubMed ID: 34519644 [TBL] [Abstract][Full Text] [Related]
45. A novel de novo KCNQ2 mutation in a child with treatmentresistant early-onset epileptic encephalopathy. Benetou C; Papailiou S; Maritsi D; Anagnostopoulou K; Kontos H; Vartzelis G Turk J Pediatr; 2019; 61(2):279-281. PubMed ID: 31951342 [TBL] [Abstract][Full Text] [Related]
46. Phenotypic and functional assessment of two novel KCNQ2 gain-of-function variants Y141N and G239S and effects of amitriptyline treatment. Bayat A; Iavarone S; Miceli F; Jakobsen AV; Johannesen KM; Nikanorova M; Ploski R; Szymanska K; Flamini R; Cooper EC; Weckhuysen S; Taglialatela M; Møller RS Neurotherapeutics; 2024 Jan; 21(1):e00296. PubMed ID: 38241158 [TBL] [Abstract][Full Text] [Related]
47. Epidemiology of Developmental and Epileptic Encephalopathy and of Intellectual Disability and Epilepsy in Children. Poke G; Stanley J; Scheffer IE; Sadleir LG Neurology; 2023 Mar; 100(13):e1363-e1375. PubMed ID: 36581463 [TBL] [Abstract][Full Text] [Related]
48. Nine patients with KCNQ2-related neonatal seizures and functional studies of two missense variants. Chokvithaya S; Caengprasath N; Buasong A; Jantasuwan S; Santawong K; Leela-Adisorn N; Tongkobpetch S; Ittiwut C; Saengow VE; Kamolvisit W; Boonsimma P; Bongsebandhu-Phubhakdi S; Shotelersuk V Sci Rep; 2023 Feb; 13(1):3328. PubMed ID: 36849527 [TBL] [Abstract][Full Text] [Related]
49. Epileptic Encephalopathy In A Patient With A Novel Variant In The Kv7.2 S2 Transmembrane Segment: Clinical, Genetic, and Functional Features. Soldovieri MV; Ambrosino P; Mosca I; Miceli F; Franco C; Canzoniero LMT; Kline-Fath B; Cooper EC; Venkatesan C; Taglialatela M Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295832 [TBL] [Abstract][Full Text] [Related]
50. Phenotypic and genetic spectrum of SCN8A-related disorders, treatment options, and outcomes. Gardella E; Møller RS Epilepsia; 2019 Dec; 60 Suppl 3():S77-S85. PubMed ID: 31904124 [TBL] [Abstract][Full Text] [Related]
51. Neonatal nonepileptic myoclonus is a prominent clinical feature of KCNQ2 gain-of-function variants R201C and R201H. Mulkey SB; Ben-Zeev B; Nicolai J; Carroll JL; Grønborg S; Jiang YH; Joshi N; Kelly M; Koolen DA; Mikati MA; Park K; Pearl PL; Scheffer IE; Spillmann RC; Taglialatela M; Vieker S; Weckhuysen S; Cooper EC; Cilio MR Epilepsia; 2017 Mar; 58(3):436-445. PubMed ID: 28139826 [TBL] [Abstract][Full Text] [Related]
52. Pathogenic variants in KCNQ2 cause intellectual deficiency without epilepsy: Broadening the phenotypic spectrum of a potassium channelopathy. Mary L; Nourisson E; Feger C; Laugel V; Chaigne D; Keren B; Afenjar A; Billette T; Trost D; Cieuta-Walti C; Gerard B; Piton A; Schaefer E Am J Med Genet A; 2021 Jun; 185(6):1803-1815. PubMed ID: 33754465 [TBL] [Abstract][Full Text] [Related]
53. Automatic and Quantitative Electroencephalographic Characterization of Drug-Resistant Epilepsy in Neonatal KCNQ2 Epileptic Encephalopathy. Zeng Z; Xu Y; Chen C; Zhou L; Wang Y; Liu M; Meng L; Zhou Y; Chen W IEEE Trans Neural Syst Rehabil Eng; 2023; 31():3004-3014. PubMed ID: 37440383 [TBL] [Abstract][Full Text] [Related]
54. Time-limited alterations in cortical activity of a knock-in mouse model of KCNQ2-related developmental and epileptic encephalopathy. Biba-Maazou N; Becq H; Pallesi-Pocachard E; Sarno S; Granjeaud S; Montheil A; Kurz M; Villard L; Milh M; Santini PL; Aniksztejn L J Physiol; 2022 May; 600(10):2429-2460. PubMed ID: 35389519 [TBL] [Abstract][Full Text] [Related]
55. Genetic testing in benign familial epilepsies of the first year of life: clinical and diagnostic significance. Zara F; Specchio N; Striano P; Robbiano A; Gennaro E; Paravidino R; Vanni N; Beccaria F; Capovilla G; Bianchi A; Caffi L; Cardilli V; Darra F; Bernardina BD; Fusco L; Gaggero R; Giordano L; Guerrini R; Incorpora G; Mastrangelo M; Spaccini L; Laverda AM; Vecchi M; Vanadia F; Veggiotti P; Viri M; Occhi G; Budetta M; Taglialatela M; Coviello DA; Vigevano F; Minetti C Epilepsia; 2013 Mar; 54(3):425-36. PubMed ID: 23360469 [TBL] [Abstract][Full Text] [Related]
56. Vitamin B6-Responsive Epilepsy due to a Novel KCNQ2 Mutation. Klotz KA; Lemke JR; Korinthenberg R; Jacobs J Neuropediatrics; 2017 Jun; 48(3):199-204. PubMed ID: 28420012 [TBL] [Abstract][Full Text] [Related]
58. Utility of genetic testing in children with developmental and epileptic encephalopathy (DEE) at a tertiary hospital in South Africa: A prospective study. Essajee F; Urban M; Smit L; Wilmshurst JM; Solomons R; van Toorn R; Moosa S Seizure; 2022 Oct; 101():197-204. PubMed ID: 36084525 [TBL] [Abstract][Full Text] [Related]
60. [Clinical and genetic characteristics of children with STXBP1 encephalopathy]. Cao JJ; Ji XN; Mao YY; Zhang PP; Liu WT; Zhang HZ; Ding N; Chen Q Zhonghua Er Ke Za Zhi; 2020 Jun; 58(6):493-498. PubMed ID: 32521962 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]